GPER promotes tamoxifen-resistance in ER+ breast cancer cells by reduced Bim proteins through MAPK/Erk-TRIM2 signaling axis
Heng Yin(Chongqing Medical University), Guanglun Yang(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Cited by 88